Author

Susan Hershenson

Observed names: S Hershenson, S. Hershenson

Observed institutions: East Tennessee State University, Gates Foundation, Amgen (United States), Genentech, Yale University

OpenAlex ID: A5069232077

Practical Approaches to Protein Formulation Development

2002 · Byeong S. Chang, Susan Hershenson · Pharmaceutical biotechnology · 95

Growth factors in porcine full and partial thickness burn repair. Differing targets and effects of keratinocyte growth factor, platelet-derived growth factor-BB, epidermal growth factor, and neu differentiation factor.

1995 · D M Danilenko, B D Ring, et al. · Europe PMC (PubMed Central) · 84

Self-Buffering Antibody Formulations

2007 · Yatin R. Gokarn, Eva Kras, et al. · Journal of Pharmaceutical Sciences · 69

Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings

2019 · Stephen E. Gerrard, Jennifer Walsh, et al. · Pharmaceutics · 62

PDF

Quality by Design for Biopharmaceutical Drug Product Development

2015 · Feroz Jameel, Susan Hershenson, et al. · AAPS advances in the pharmaceutical sciences series · 59

A Compendium and Hydropathy/ Flexibility Analysis of Common Reactive Sites in Proteins: Reactivity at Asn, Asp, Gin, and Met Motifs in Neutral pH Solution

2002 · Michael F. Powell, Godfrey Amphlett, et al. · Pharmaceutical biotechnology · 24

Purification and crystallization of creatine kinase from rabbit skeletal muscle.

1986 · S Hershenson, N Helmers, et al. · Journal of Biological Chemistry · 23

Two Decades of Publishing Excellence in Pharmaceutical Biotechnology

2014 · David B. Volkin, Susan Hershenson, et al. · Journal of Pharmaceutical Sciences · 20

Sorbitol Crystallization-Induced Aggregation in Frozen mAb Formulations

2014 · Deirdre Murphy Piedmonte, Alison Hair, et al. · Journal of Pharmaceutical Sciences · 16

PDF

Kinetic studies of the glycerophosphate acyltransferase from Euglena microsomes, including the effects of serum albumin

1983 · Susan Hershenson, Mary Lou Ernst-Fonberg · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 14

The Structure of Biological Therapeutics

2010 · Sheryl Martin‐Moe, Tim Osslund, et al. · Wiley eBooks · 11

Isolation of sn‐glycerol‐3‐phosphate acyltransferase from achloroplastic Euglena

1979 · Laura V. Grobovsky, Susan Hershenson, et al. · FEBS Letters · 8

PDF

Isoelectric focusing of recombinant interferon-beta.

1989 · S Hershenson, J Thomson · PubMed · 6

Comparison of glycerophosphate acyltransferases from Euglena chloroplasts and microsomes

1983 · Susan Hershenson, Beverly A. Boehler-Kohler, et al. · Archives of Biochemistry and Biophysics · 6

Drug–Drug Interactions of Infectious Disease Treatments in Low‐Income Countries: A Neglected Topic?

2019 · Savannah J. McFeely, Jingjing Yu, et al. · Clinical Pharmacology & Therapeutics · 5

PDF

Comparison of 1-acylglycerophosphate and glycerophosphate acyltransferases from Euglena microsomes

1984 · Susan Hershenson, Mary Lou Ernst-Fonberg · International Journal of Biochemistry · 4

Application of exposure bracketing to streamline the development of contraceptive products

2022 · Joshua Brown, Tamra Goodrow, et al. · Contraception X · 2

PDF

571 Targeting the GLUT1 Transporter as a Novel Therapeutic Approach to Exploit the Dependency of Cancer Cells On the “Warburg Effect”

2012 · D.A. Chan, P. Pearson, et al. · European Journal of Cancer

410 Circumventing Paradoxical Drug-induced Activation of the MAPK Pathway with Next Generation B-RAF V600E Inhibitors

2012 · J.M. Vernier, D. Matthews, et al. · European Journal of Cancer

Frontmatter

2010 · Feroz Jameel, Susan Hershenson · Wiley eBooks

PDF

Works count: 21

Citation count: 508

H-index: 11

I10-index: 11